0
ARTICLE |

Misdiagnosis of Multidrug-Resistant Tuberculosis Possibly Due to Laboratory-Related Errors FREE

Annette Tsugie Nitta, MD; Paul Titus Davidson, MD; Muriel Lucille de Koning, RN; Robert Joseph Kilman
[+] Author Affiliations

Presented in poster form at the American Thoracic Society Meeting, Seattle, Wash, May 20-24, 1995.

Corresponding author: Annette T. Nitta, MD, TB Control, 2615 S Grand Ave, Room 507, Los Angeles, CA 90007.

Toward Optimal Laboratory Use section editor: George D. Lundberg, MD, Editor, JAMA.


JAMA. 1996;276(24):1980-1983. doi:10.1001/jama.1996.03540240058032
Text Size: A A A
Published online

Objective.  —To describe 9 cases where a misdiagnosis of multidrug-resistant tuberculosis (MDR TB) was made, possibly due to laboratory-related errors.

Design.  —Case series.

Setting.  —Public and private hospitals, outpatient clinics, and mycobacteriology laboratories serving those institutions in Los Angeles County, Calif.

Patients.  —Consecutive sample of 70 patients diagnosed with MDR TB who were identified between August 1993 and August 1994 by the Multidrug-Resistant Unit within TB Control in Los Angeles County.

Outcome Measure.  —Detection of laboratory-related diagnostic errors.

Results.  —Pulmonary MDR TB was misdiagnosed in 9 (13%) of 70 patients. Reasons why the diagnoses appeared to be erroneous are as follows: growth of MDR TB from an old tuberculous lesion in a patient who was never treated for TB and whose diagnosis predated anti-TB drugs (1 case), documented contamination with Mycobacterium avium complex (1 case), suspected cross-contamination (1 case), suspected specimen mislabeling (1 case), successful treatment using drugs to which the isolate was reportedly resistant (4 cases), discrepant susceptibility test results on additional sputum specimens submitted by the patient (2 cases), and no clinical evidence of TB (3 cases).

Conclusions.  —These cases emphasize the diagnostic errors that can occur if mycobacterial susceptibility results are not correlated with all clinical data including other laboratory results for a given patient. We conclude that susceptibility results alone are not enough to dictate treatment, and that careful clinical correlation is necessary in making the diagnosis of MDR TB.

REFERENCES

Tenover FC, Crawford JT, Heubner RE, Geiter LF, Horsburgh CR, Good RC.  The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol . 1993;;31:767-770.
Maloney SA, Pearson ML, Gordon MT, Del Castillo R, Boyle JF, Jarvis WR.  Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers . Ann Intern Med . 1995;;122:90-95.
Vareldzis BP, Grosset J, de Kantor I, et al.  Drugresistant tuberculosis: laboratory issues . Tuber Lung Dis . 1994;;75:1-7.
Bloch AB, Cauthen GM, Onorato IM, et al.  Nationwide survey of drug-resistant tuberculosis in the United States . JAMA . 1994;;271:665-671.
D'Esposo ND.  Clinical trials in pulmonary tuberculosis . Am Rev Respir Dis . 1982;;125( (3) [pt 2]):85-93.
Noordhoek GT, Kolk AHJ, Bjune G, et al.  Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories . J Clin Microbiol . 1994;;32:277-284.
Butler WR, O'Connor SP, Yakrus MA, Gross WM.  Cross-reactivity of genetic probe for detection of Mycobacterium tuberculosis with newly described species Mycobacterium celatum . J Clin Microbiol . 1994;;32:536-538.
Schluger NW, Kinney D, Harkin TJ, Rom WN.  Clinical utility of the polymerase chain reaction in the diagnosis of infections due to Mycobacterium tuberculosis . Chest . 1994;;105:1116-1121.
Dunlap NE, Harris RH, Benjamin WH Jr, Harden JW, Hafner D.  Laboratory contamination of Mycobacterium tuberculosis cultures . Am J Respir Crit Care Med . 1995;;152:1702-1704.
Hewlett D Jr, Horn DL, Alfalla C.  Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing . JAMA . 1995;;273:916-917.
Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr.  Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin . N Engl J Med . 1993;;328:527-532.
Iseman MD.  Treatment of multidrug-resistant tuberculosis . N Engl J Med . 1993;;329:784-791.
Dooley SW, Jarvis WR, Martone WJ, Snider DE Jr.  Multidrug-resistant tuberculosis . Ann Intern Med . 1992;;117:257-259.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Tenover FC, Crawford JT, Heubner RE, Geiter LF, Horsburgh CR, Good RC.  The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol . 1993;;31:767-770.
Maloney SA, Pearson ML, Gordon MT, Del Castillo R, Boyle JF, Jarvis WR.  Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers . Ann Intern Med . 1995;;122:90-95.
Vareldzis BP, Grosset J, de Kantor I, et al.  Drugresistant tuberculosis: laboratory issues . Tuber Lung Dis . 1994;;75:1-7.
Bloch AB, Cauthen GM, Onorato IM, et al.  Nationwide survey of drug-resistant tuberculosis in the United States . JAMA . 1994;;271:665-671.
D'Esposo ND.  Clinical trials in pulmonary tuberculosis . Am Rev Respir Dis . 1982;;125( (3) [pt 2]):85-93.
Noordhoek GT, Kolk AHJ, Bjune G, et al.  Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories . J Clin Microbiol . 1994;;32:277-284.
Butler WR, O'Connor SP, Yakrus MA, Gross WM.  Cross-reactivity of genetic probe for detection of Mycobacterium tuberculosis with newly described species Mycobacterium celatum . J Clin Microbiol . 1994;;32:536-538.
Schluger NW, Kinney D, Harkin TJ, Rom WN.  Clinical utility of the polymerase chain reaction in the diagnosis of infections due to Mycobacterium tuberculosis . Chest . 1994;;105:1116-1121.
Dunlap NE, Harris RH, Benjamin WH Jr, Harden JW, Hafner D.  Laboratory contamination of Mycobacterium tuberculosis cultures . Am J Respir Crit Care Med . 1995;;152:1702-1704.
Hewlett D Jr, Horn DL, Alfalla C.  Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing . JAMA . 1995;;273:916-917.
Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr.  Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin . N Engl J Med . 1993;;328:527-532.
Iseman MD.  Treatment of multidrug-resistant tuberculosis . N Engl J Med . 1993;;329:784-791.
Dooley SW, Jarvis WR, Martone WJ, Snider DE Jr.  Multidrug-resistant tuberculosis . Ann Intern Med . 1992;;117:257-259.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.